[Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)].
D000284:Administration, Oral; D000404:Ajmaline / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000814:Aniline Compounds; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004048:Diethylamines; D004206:Disopyramide / Q000008:administration & dosage / Q000627:therapeutic use; D004285:Dogs; D006352:Heart Ventricles; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D007267:Injections; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy; D011217:Practolol / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007189:Indans; D000404:Ajmaline; D011433:Propranolol; D004206:Disopyramide; D011802:Quinidine; D011342:Procainamide; D011217:Practolol
Valeur therapeutique des médicaments du rythme cardiaque et problèmes pratiques que soulève leur utilisation en clinique